What is the dose of Griseofulvin (antifungal medication) for an 8-year-old pediatric patient weighing 35 kg with ringworm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Griseofulvin Dosing for Pediatric Ringworm

For your 35 kg, 8-year-old patient with ringworm, give griseofulvin 700 mg daily (20 mg/kg/day) with a fatty meal for 6-8 weeks. 1

Specific Dosing Calculation

  • Standard dose: 20 mg/kg/day in single or divided doses for patients under 50 kg 1, 2
  • For this 35 kg patient: 700 mg daily (35 kg × 20 mg/kg = 700 mg)
  • Duration: 6-8 weeks for tinea capitis (scalp ringworm) 1
  • Administration: Give with fatty food to enhance absorption and bioavailability 1, 2, 3

Dosing Range and Adjustments

  • The British Association of Dermatologists guidelines specify 15-20 mg/kg/day as the standard range 2, 4
  • May increase up to 25 mg/kg/day (875 mg for this patient) for resistant cases or prolonged treatment 1, 2
  • Can be given as single daily dose or divided doses 1

Critical Treatment Considerations

Species-Specific Efficacy

  • Microsporum species: 88.5% response rate with griseofulvin 1
  • Trichophyton species: 67.9% response rate - may require higher doses (up to 25 mg/kg/day) and longer duration (12-18 weeks) 1, 2
  • Treatment should ideally be guided by culture results, though empiric therapy is reasonable with typical clinical features 1

Administration Pearls

  • Fatty meal significantly increases absorption: In pediatric studies, giving griseofulvin with milk resulted in 4-fold higher peak serum concentrations and 10-fold larger area under the curve compared to fasting administration 3
  • Peak serum levels occur approximately 4 hours after oral administration 3, 4

Safety Profile

Common Side Effects

  • Gastrointestinal disturbances and rashes in <8% of patients 1
  • Headaches may occur 2, 4
  • Very few patients (0.8%) require discontinuation 1
  • Well-tolerated in children 4

Contraindications

  • Lupus erythematosus, porphyria, severe liver disease 1, 2

Drug Interactions

  • Rifampicin decreases plasma concentration 1, 2
  • Cimetidine increases plasma concentration 1, 2
  • Barbiturates decrease griseofulvin activity 3

Treatment Monitoring

  • Endpoint should be mycological cure, not just clinical improvement 1, 2
  • Repeat mycology sampling recommended until clearance is achieved 1, 2
  • Consider treatment failure causes: non-compliance, suboptimal absorption, organism resistance, or reinfection 2

Adjunctive Measures

  • Add topical antifungal shampoo (ketoconazole 2%, selenium sulfide 1%, or povidone-iodine) to reduce spore transmission 1
  • Screen and treat family members - over 50% may be affected with anthropophilic species like T. tonsurans 1
  • Disinfect hairbrushes and combs with bleach or 2% sodium hypochlorite solution 1
  • Child can attend school while on appropriate systemic and topical therapy 1

Formulation Notes

  • Griseofulvin is available as micronized, ultramicronized, and suspension forms 1
  • The suspension allows more accurate dosage adjustments in children but has become increasingly expensive and less available 1
  • Griseofulvin remains the only licensed product for tinea capitis in children in many countries 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Griseofulvin Treatment Guidelines for Fungal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Griseofulvin].

Annales de dermatologie et de venereologie, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.